SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-036669
Filing Date
2022-12-28
Accepted
2022-12-28 16:38:08
Documents
1
Period of Report
2022-12-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3118
  Complete submission text file 0001493152-22-036669.txt   4556
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Issuer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 402-1 SCOTT ST.` TORONTO A6 M5E 1A1
Business Address
Bondarenko Jamieson (Reporting) CIK: 0001942516 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40101 | Film No.: 221495035